REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medicament Sp. z o.o. (Szczecin) (Poland)

Main Activities: Department Stores
Full name: Medicament Sp. z o.o. Profile Updated: April 21, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Medicament Sp. z o.o. (Szczecin) is based in Poland, with the head office in Szczecin. It operates in the Department Stores industry. It was first established on July 26, 2004. There are currently 1 (2013) people employed by Medicament Sp. z o.o. (Szczecin). The latest financial highlights indicate a net sales revenue increase of 21.35% in 2023. Over the same period, its total assets decreased by 16.67%.

Headquarters
Ul. Wincentego Kadlubka 10/11
Szczecin; Zachodniopomorskie; Postal Code: 71-521

Contact Details: Purchase the Medicament Sp. z o.o. (Szczecin) report to view the information.

Website: http://www.przychodnie-fabian.pl

Basic Information
Total Employees:
Purchase the Medicament Sp. z o.o. (Szczecin) report to view the information.
Outstanding Shares:
Purchase the Medicament Sp. z o.o. (Szczecin) report to view the information.
Registered Capital:
Purchase the Medicament Sp. z o.o. (Szczecin) report to view the information.
Incorporation Date:
July 26, 2004
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
44%
Purchase this report to view the information.
40%
Purchase this report to view the information.
16%
Company Performance
Financial values in the chart are available after Medicament Sp. z o.o. (Szczecin) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
21.35%▲
Total operating revenue
21.35%▲
Operating profit (EBIT)
N/A
EBITDA
-83.96%▼
Net Profit (Loss) for the Period
N/A
Total assets
-16.67%▼
Total equity
-67.64%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
34.7%▲
Quick Ratio
-0.31%▼
Cash Ratio
-0.32%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo